Related references
Note: Only part of the references are listed.Recent advances and clinical application of erythropoietin and erythropoiesis-stimulating agents
Tetsuhiro Tanaka et al.
EXPERIMENTAL CELL RESEARCH (2012)
Peginesatide and erythropoietin stimulate similar erythropoietin receptor-mediated signal transduction and gene induction events
Jennifer M. Green et al.
EXPERIMENTAL HEMATOLOGY (2012)
The use of genes for performance enhancement: doping or therapy?
R. S. Oliveira et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2011)
Dose-finding Study of Peginesatide for Anemia Correction in Chronic Kidney Disease Patients
Iain C. Macdougall et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Screen and confirmation of PEG-epoetin beta in equine plasma
Y. Chang et al.
DRUG TESTING AND ANALYSIS (2011)
The overlooked difference between human endogenous and recombinant erythropoietins and its implication for sports drug testing and pharmaceutical drug design
Christian Reichel
DRUG TESTING AND ANALYSIS (2011)
Development of liquid chromatography-tandem mass spectrometry-based analytical assays for the determination of HIF stabilizers in preventive doping research
Simon Beuck et al.
DRUG TESTING AND ANALYSIS (2011)
Methods for detection and confirmation of Hematide™/peginesatide in anti-doping samples
Nicolas Leuenberger et al.
FORENSIC SCIENCE INTERNATIONAL (2011)
How to confirm CERA doping in athletes' blood?
Nicolas Leuenberger et al.
FORENSIC SCIENCE INTERNATIONAL (2011)
Direct and long-term detection of gene doping in conventional blood samples
T. Beiter et al.
GENE THERAPY (2011)
Longevity of rAAV vector and plasmid DNA in blood after intramuscular injection in nonhuman primates: implications for gene doping
W. Ni et al.
GENE THERAPY (2011)
Synthesis, characterisation, and mass spectrometric detection of a pegylated EPO-mimetic peptide for sports drug testing purposes
Ines Moeller et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2011)
Prolyl Hydroxylases and Therapeutics
Thomas G. Smith et al.
ANTIOXIDANTS & REDOX SIGNALING (2010)
Defending Dynepo detection
Guenter Gmeiner et al.
DRUG TESTING AND ANALYSIS (2010)
IEF pattern classification-derived criteria for the identification of epoetin-δ in urine
Severine Lamon et al.
ELECTROPHORESIS (2010)
Mass spectrometry-based characterization of new drugs and methods of performance manipulation in doping control analysis
Mario Thevis et al.
EUROPEAN JOURNAL OF MASS SPECTROMETRY (2010)
Gene doping detection: evaluation of approach for direct detection of gene transfer using erythropoietin as a model system
A. Baoutina et al.
GENE THERAPY (2010)
Detection of His-tagged Long-R3-IGF-I in a black market product
Maxie Kohler et al.
GROWTH HORMONE & IGF RESEARCH (2010)
Inhibition of Prolyl Hydroxylases Increases Erythropoietin Production in ESRD
Wanja M. Bernhardt et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Hypoxic regulation of erythropoiesis and iron metabolism
Volker H. Haase
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Hypoxia, hypoxia-inducible factors (HIF), HIF hydroxylases and oxygen sensing
James D. Webb et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Effects of Exercise on the Isoelectric Patterns of Erythropoietin
Severine Lamon et al.
CLINICAL JOURNAL OF SPORT MEDICINE (2009)
Erythropoiesis Stimulating Agents and Techniques: A Challenge for Doping Analysts
W. Jelkmann
CURRENT MEDICINAL CHEMISTRY (2009)
SDS-PAGE of recombinant and endogenous erythropoietins: benefits and limitations of the method for application in doping control
Christian Reichel et al.
DRUG TESTING AND ANALYSIS (2009)
SARCOSYL-PAGE: a new method for the detection of MIRCERA- and EPO-doping in blood
Christian Reichel et al.
DRUG TESTING AND ANALYSIS (2009)
Detection of continuous erythropoietin receptor activator in blood and urine in anti-doping control
Francoise Lasne et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
A high-throughput test to detect CERA doping in blood
Severine Lamon et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2009)
Biosafety in Ex Vivo Gene Therapy and Conditional Ablation of Lentivirally Transduced Hepatocytes in Nonhuman Primates
Olivier Menzel et al.
MOLECULAR THERAPY (2009)
Structural analysis of the glycosylation of gene-activated erythropoietin (epoetin delta, Dynepo)
Esther Llop et al.
ANALYTICAL BIOCHEMISTRY (2008)
Discrimination of recombinant and endogenous urinary erythropoietin by calculating relative mobility values from SDS gels
M. Kohler et al.
INTERNATIONAL JOURNAL OF SPORTS MEDICINE (2008)
Identification of zinc-alpha-2-glycoprotein binding to clone AE7A5 antihuman EPO antibody by means of nano-HPLC and high-resolution high-mass accuracy ESI-MS/MS
Christian Reichel
JOURNAL OF MASS SPECTROMETRY (2008)
Hematide is immunologically distinct from erythropoietin and corrects anemia induced by antierythropoietin antibodies in a rat pure red cell aplasia model
Kathryn W. Woodburn et al.
EXPERIMENTAL HEMATOLOGY (2007)
Isoelectric profiles of human erythropoietin are different in serum and urine
Francoise Lasne et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2007)
FcRn: the neonatal Fc receptor comes of age
Derry C. Roopenian et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Pharmacokinetics and pharmacodynamics of intravenous and subcutaneous Continuous Erythropoietin Receptor Activator (CERA) in patients with chronic kidney disease
Iain C. Macdougall et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Pulmonary administration of therapeutic proteins using an immunoglobulin transport pathway
Alan J. Bitonti et al.
ADVANCED DRUG DELIVERY REVIEWS (2006)
Preclinical evaluation of Hematide, a novel erythropoiesis stimulating agent, for the treatment of anemia
Qing Fan et al.
EXPERIMENTAL HEMATOLOGY (2006)
Evaluation of the safety and pharmacodynamics of Hematide, a novel erythropoietic agent, in a phase 1, double-blind, placebo-controlled, dose-escalation study in healthy volunteers
Richard B. Stead et al.
BLOOD (2006)
Long-term doxycycline-regulated transgene expression in the retina of nonhuman primates following subretinal injection of recombinant AAV vectors
Knut Stieger et al.
MOLECULAR THERAPY (2006)
Ex vivo transduction of human dermal tissue structures for autologous implantation production and delivery of therapeutic proteins
E Brill-Almon et al.
MOLECULAR THERAPY (2005)
Genetic Doping with erythropoietin cDNA in primate muscle is detectable
F Lasne et al.
MOLECULAR THERAPY (2004)
Recombinant adeno-associated virus serotype 4 mediates unique and exclusive long-term transduction of retinal pigmented epithelium in rat, dog, and nonhuman primate after subretinal delivery
M Weber et al.
MOLECULAR THERAPY (2003)
Detection of isoelectric profiles of erythropoietin in urine: differentiation of natural and administered recombinant hormones
F Lasne et al.
ANALYTICAL BIOCHEMISTRY (2002)
Long-term reversal of chronic anemia using a hypoxia-regulated erythropoietin gene therapy
K Binley et al.
BLOOD (2002)
Receptor-mediated immunoglobulin G transport across mucosal barriers in adult life: Functional expression of FcRn in the mammalian lung
GM Spiekermann et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Strategies for rhEPO detection in sport
R Kazlauskas et al.
CLINICAL JOURNAL OF SPORT MEDICINE (2002)
Sugar profiling proves that human serum erythropoietin differs from recombinant human erythropoietin
V Skibeli et al.
BLOOD (2001)
Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model
A Auricchio et al.
HUMAN MOLECULAR GENETICS (2001)
Structural analysis of sulfated N-linked oligosaccharides in erythropoietin
N Kawasaki et al.
GLYCOBIOLOGY (2001)
Double-blotting: a solution to the problem of non-specific binding of secondary antibodies in immunoblotting procedures
F Lasne
JOURNAL OF IMMUNOLOGICAL METHODS (2001)
Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation
P Jaakkola et al.
SCIENCE (2001)
Development and characterization of novel erythropoiesis stimulating protein (NESP)
JC Egrie et al.
BRITISH JOURNAL OF CANCER (2001)
Recombinant erythropoietin in urine - An artificial hormone taken to boost athletic performance can now be detected.
F Lasne et al.
NATURE (2000)
Share Paper
